Send me a link:

*Text messaging rates may apply.

 Dow Down0.80% Nasdaq Down0.56%

Charles River Laboratories International, Inc. (CRL)

53.83 Up 0.09(0.17%) 2:34PM EDT - NYSE Real Time Price
ProfileGet Profile for:
Charles River Laboratories International, Inc.
251 Ballardvale Street
Wilmington, MA 01887
United States - Map
Phone: 781-222-6000

Index Membership:N/A
Industry:Medical Laboratories & Research
Full Time Employees:7,700

Business Summary 

Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. It operates through two segments, Research Models and Services (RMS), and Preclinical Services (PCS). The RMS segment produces and sells research model strains, principally genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist customers in the drug discovery and development process, which include genetically engineered models and services, insourcing solutions, discovery research services, and research animal diagnostic services; endotoxin and microbial detection products and services; and avian vaccine products and services. The PCS segment provides preclinical services, including in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. This segment offers services in the areas of bioanalysis, pharmacokinetics, and drug metabolism; toxicology; and pathology services, as well as testing of biologics and devices frequently outsourced by pharmaceutical and biotechnology companies. The company serves pharmaceutical companies, biotechnology companies, government agencies, hospitals, and academic institutions worldwide. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Charles River Laboratories International, Inc.

Corporate Governance 
Charles River Laboratories International, Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 3. The pillar scores are Audit: 5; Board: 4; Shareholder Rights: 4; Compensation: 4.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. James C. Foster J.D., 63
Chairman, Chief Exec. Officer, Pres, Chairman of Exec. Committee and Member of Strategic Planning & Capital Allocation Committee
Mr. Thomas F. Ackerman , 59
Chief Financial Officer and Corp. Exec. VP
Dr. Nancy A. Gillett D.V.M, Ph.D., D.A.C.V.P., 58
Chief Scientific officer and Corp. Exec. VP
Mr. David P. Johst , 52
Chief Admin. Officer, Corp. Exec. VP of HR, Gen. Counsel and Sec.
Dr. Davide A. Molho D.V.M., 44
Corp. Exec. VP and Pres of Global Research Models & Services & Preclinical Services Operations
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders